Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2

Hematology Journal

Volumn 1, Issue 4, 2000, Pages 254-263

  Valk, Peter ^a   Verbakel, Sandra ^a   Von Lindern, Marieke ^a   Löwenberg, Bob ^a   Delwel, Ruud ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Anandamide; Cb2; ERK1 2; Erythropoietin

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; AMIDE; ANANDAMIDE; ARACHIDONIC ACID DERIVATIVE; BORNANE DERIVATIVE; CANNABINOID RECEPTOR; DNA BINDING PROTEIN; DRUG RECEPTOR; ERYTHROPOIETIN; MESSENGER RNA; MILK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN C FOS; PYRAZOLE DERIVATIVE; STAT5 PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CYCLE; CELL LINE; CULTURE MEDIUM; DNA REPLICATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; GENETICS; METABOLISM; MOUSE; ONCOGENE; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; APOPTOSIS; ARACHIDONIC ACIDS; BORNANES; CELL CYCLE; CELL LINE; CULTURE MEDIA, SERUM-FREE; DNA REPLICATION; DNA-BINDING PROTEINS; DRUG SYNERGISM; ENZYME ACTIVATION; ERYTHROPOIETIN; GENES, FOS; MICE; MILK PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; POLYUNSATURATED ALKAMIDES; PROTO-ONCOGENE PROTEINS C-FOS; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; UP-REGULATION;

EID: 0034585294     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200036     Document Type: Article

References (31)

1. Krantz SB. Erythropoietin. Blood 77: 419, 1991.
2. Sui X, Krantz SB, You M, Zhao Z. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. Blood 92: 1142, 1998.
3. Valk P, Verbakel S, Vankan Y, Hol S, Mancham S, Ploemacher R, Mayen A, Lowenberg B, Delwel R. Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells. Blood 90: 1448, 1997.
4. Derocq JM, Bouaboula M, Marchand J, Rinaldi-Carmona M, Segui M, Casellas P. The endogenous cannabinoid Anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. FEBS Letters 425: 419, 1998.
5. Migliaccio G, Migliaccio AR, Kreider BL, Rovera G, Adamson JW. Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D. Journal of Cell Biology 109: 833, 1989.
6. Gouilleux F, Pallard C, Dusanter-Fourt I, Wakao H, Haldosen LA, Norstedt G, Levy D, Groner B. Prolactin, growth hormone, erythropoietin and granulocyte-macro-phage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO Journal 14: 2005, 1995.
7. Miura Y, Miura O, Ihle JN, Aoki N. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. Journal of Biological Chemistry 269: 29962, 1994.
8. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, Cobb MH, Shaw PE. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO Journal 14: 951, 1995.
9. Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, Portier M, Shire D, Breliere JC, Le Fur GL. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. Journal of Pharmacology and Experimental Therapeutics 284: 644, 1998.
10. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrié P, Breliére JC, Le Fur G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letters 350: 240, 1994.
11. Badley JE, Bishop GA, St. John T, Frelinger JA. A simple, rapid method for the purification of poly A+ RNA. Biotechniques 6: 114, 1988.
12. Valk PJ, Hol S, Vankan Y, Ihle JN, Askew D, Jenkins NA, Gilbert DJ, Copeland NG, de Both NJ, Lowenberg B, Delwel R. The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11. Journal of Virology 71: 6796, 1997.
13. Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K, Devane WA. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proceedings of the National Academy of Sciences, USA 90: 7656, 1993.
14. Seger R, Krebs EG. The MAPK signalling cascade. FASEB Journal 9: 726, 1995.
15. van Biesen T, Luttrell LM, Hawes BE, Lefkowitz RJ. Mitogenic signalling via G protein-coupled receptors. Endocrinological Reviews 17: 698, 1996.
16. Marshall CJ. Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179, 1995.
17. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74: 227, 1993.
18. Derkinderen P, Toutant M, Burgaya F, Le Bert M, Siciliano JC, de Franciscis V, Gelman M, Girault JA. Regulation of a neuronal form of focal adhesion kinase by Anandamide. Science 273: 1719, 1996.
19. Zachary I. Focal adhesion kinase. International Journal of Biochemical Cell Biology 29: 929, 1997.
20. Miyamoto S, Teramoto H, Gutkind JS, Yamada KM. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. Journal of Cell Biology 135: 1633, 1996.
21. Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrie B, Rinaldi-Carmona M, Calandra B, Le Fur G, Casellas P. Signalling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. European Journal of Biochemistry 237: 704, 1996.
22. Wartmann M, Campbell D, Subramanian A, Burstein SH, Davis RJ. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid Ana. FEBS Letters 359: 133, 1995.
23. Carayon P, Marchand J, Dussossoy D, Derocq JM, Jbilo O, Bord A, Bouaboula M, Galiegue S, Mondiere P, Penarier G, Fur GL, Defrance T, Casellas P. Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood 92: 3605, 1998.
24. Graber MN, Alfonso A, Gill DL. Ca2+ pools and cell growth: arachidonic acid induces recovery of cells growth-arrested by Ca2+ pool depletion. Journal of Biological Chemistry 271: 883, 1996.
25. Peppelenbosch MP, Qiu RG, de Vries-Smits AM, Tertoolen LG, de Laat SW, McCormick F, Hall A, Symons MH, Bos JL. Rac mediates growth factor-induced arachidonic acid release. Cell 81: 849, 1995.
26. Hunter SA, Burstein SH. Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and Anandamide synthesis. Life Sciences 60: 1563, 1997.
27. Bisogno T, Maurelli S, Melck D, De Petrocellis L, Di Marzo V. Biosynthesis, uptake, and degradation of Anandamide and palmitoylethanolamide in leukocytes. Journal of Biological Chemistry 272: 3315, 1997.
28. Valk PJM, Delwel R. The peripheral cannabinoid receptor, Cb2, in retrovirally-induced leukemic transformation and normal hematopoiesis. Leukemia and Lymphoma 32: 29, 1998.
29. Treisman R. Journey to the surface of the cell: Fos regulation and the SRE. EMBO Journal 14: 4905, 1995.
30. Buchberg AM, Bedigian HG, Jenkins NA, Copeland NG. Evi-2, a common integration site involved in murine myeloid leukemogenesis. Molecular and Cellular Biology 10: 4658, 1990.
31. Ihle JN, Rein A, Mural R. Immunological and virological mechanisms in retrovirus-induced murine leukemogenesis. Viral Oncology 4: 95, 1984.